Search

everythinglearnresearchcommunity

for

Search:↓

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Insulin resistance increases the risk of developing type 2 diabetes and other health issues.

Finasteride, a drug used for certain conditions, can cause serious side effects like sexual dysfunction, suicidal thoughts, and increased diabetes risk, and there's a need for more awareness and research about these effects.

Type 2 immunity helps control mite growth in hair follicles, preventing damage.

The article suggests renaming Polycystic Ovarian Syndrome (PCOS) to "Hyperandrogenic Persistent Ovulatory Dysfunction Syndrome" (HA-PODS) for accuracy and consistency, but no final decision was made.

Polycystic Ovary Syndrome (PCOS) is common in women with conditions like anovulation, hirsutism, hair loss, and type 2 diabetes, and it can lead to health risks like heart disease, obesity, insulin resistance, and depression. Non-Classic Congenital Adrenal Hyperplasia (NC-CAH) is also discussed.

The document concludes that careful history and physical exams are crucial for accurately diagnosing polycystic ovary syndrome and distinguishing it from other similar conditions.

The document concludes that accurate diagnosis and management of PCOS are crucial due to its associated health risks.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

Diabetic neuropathy in mice is linked to poor mitochondria function and lower brain hormone production.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Certain drugs that block specific enzymes can help treat prostate diseases.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.

Lespedeza cuneata extract may help treat enlarged prostate.

Honokiol might help reduce male skin aging by maintaining testosterone levels.

A specific enzyme is essential for proper hair follicle stem cell development and healthy skin.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

Androgens like testosterone affect skin health and can lead to conditions such as acne and hair loss, with various treatments available.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

Testosterone and dihydrotestosterone treatments can help with penile growth in males with 5α-reductase type 2 deficiency, with dihydrotestosterone being more effective in infancy.

Trazodone might help reverse post finasteride syndrome.

Maxillariinae orchids contain 62 compounds with potential health benefits, including treating skin conditions and diseases like cancer and diabetes.

Ozone therapy might improve cancer treatment and reduce its side effects.

Dihydrotestosterone treatment can help penis growth in boys with 5α-reductase deficiency but doesn't fully normalize size after puberty.